2023 Q4 Form 10-Q Financial Statement

#000164033423002222 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $521.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $58.99K $18.60K $25.88K
YoY Change 17.98% -28.13% 71.39%
% of Gross Profit
Research & Development $18.88K $47.21K $0.00
YoY Change -61.82%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $77.87K $65.80K $25.88K
YoY Change -24.37% 154.31% 71.36%
Operating Profit -$77.35K -$65.80K -$25.88K
YoY Change -24.87% 154.31%
Interest Expense $47.45K $106.3K $0.00
YoY Change -36.92%
% of Operating Profit
Other Income/Expense, Net -$38.54K -$115.6K $0.00
YoY Change -47.64%
Pretax Income -$115.9K -$181.4K -$25.88K
YoY Change -34.37% 600.87% 71.39%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$115.9K -$181.4K -$25.88K
YoY Change -34.37% 601.01% 71.36%
Net Earnings / Revenue -22243.38%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 -$647.00
COMMON SHARES
Basic Shares Outstanding 23.96M shares 60.00M shares
Diluted Shares Outstanding 37.16M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.500K $12.33K
YoY Change -95.0%
Cash & Equivalents $2.503K $12.33K $0.00
Short-Term Investments
Other Short-Term Assets $161.9K $12.50K $7.050K
YoY Change 77.3% 182.0%
Inventory
Prepaid Expenses $7.045K
Receivables
Other Receivables
Total Short-Term Assets $213.1K $58.87K $7.045K
YoY Change 359.54% 735.57% 73.1%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $258.0K $258.0K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $213.1K $58.87K $7.045K
Total Long-Term Assets $258.0K $258.0K $0.00
Total Assets $471.1K $316.9K $7.045K
YoY Change 915.95% 4397.74% 73.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $72.61K $61.69K $15.15K
YoY Change 263.05% 307.19% -26.99%
Accrued Expenses $27.55K $18.30K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $680.1K $595.6K $0.00
YoY Change 223.84%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $842.9K $733.6K $65.50K
YoY Change 197.73% 1020.15% -51.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $842.9K $733.6K $65.50K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $842.9K $733.6K $65.50K
YoY Change 197.73% 1020.15% -51.35%
SHAREHOLDERS EQUITY
Retained Earnings -$1.007M -$891.5K -$243.9K
YoY Change 78.65% 265.57% 35.03%
Common Stock $365.00 $237.00 $400.00
YoY Change -8.75% -40.75% 419.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$371.8K -$416.8K -$58.45K
YoY Change
Total Liabilities & Shareholders Equity $471.1K $316.9K $7.045K
YoY Change 915.95% 4397.74% 73.1%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$115.9K -$181.4K -$25.88K
YoY Change -34.37% 601.01% 71.36%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$43.11K -$129.1K $0.00
YoY Change -52.1% -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$13.74K -$17.31K
YoY Change
Cash From Investing Activities -$13.74K -$17.31K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 57.30K 151.9K 0.000
YoY Change -59.07% -100.0%
NET CHANGE
Cash From Operating Activities -43.11K -129.1K 0.000
Cash From Investing Activities -13.74K -17.31K
Cash From Financing Activities 57.30K 151.9K 0.000
Net Change In Cash 450.0 5.500K 0.000
YoY Change -99.1% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$43.11K -$129.1K $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Income Loss
NetIncomeLoss
-327632 usd
caro Foreign Currency Exchange Rate Translation Average Gbp Usd Exchange Rate
ForeignCurrencyExchangeRateTranslationAverageGbpUsdExchangeRate
1.2591 pure
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
566666 shares
CY2022Q4 caro Stock Purchase Agreement For Acquisition
StockPurchaseAgreementForAcquisition
20000000 shares
CY2023Q1 us-gaap Share Price
SharePrice
0.0129
CY2023Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
258000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
258000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
18429 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
36857 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
36857 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
36857 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
36857 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
92143 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
258000 usd
us-gaap Proceeds From Sale Of Loans Receivable
ProceedsFromSaleOfLoansReceivable
33305 usd
CY2023 us-gaap Proceeds From Sale Of Loans Receivable
ProceedsFromSaleOfLoansReceivable
6000 usd
CY2023Q3 us-gaap Interest Receivable
InterestReceivable
531 usd
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
13 usd
CY2022Q4 caro Promissory Note Bears Interest Rate
PromissoryNoteBearsInterestRate
0.08 pure
CY2023Q2 caro Unaffiliated Party Promissory Note Principal Amount
UnaffiliatedPartyPromissoryNotePrincipalAmount
3900 usd
CY2023Q2 caro Promissory Note Bears Interest Rate
PromissoryNoteBearsInterestRate
0.08 pure
CY2023Q3 us-gaap Notes Payable
NotesPayable
28900 usd
CY2023Q1 us-gaap Notes Payable
NotesPayable
25000 usd
CY2023Q3 caro Accrued Interest
AccruedInterest
2092 usd
CY2023Q1 caro Accrued Interest
AccruedInterest
948 usd
CY2023Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
566665 usd
CY2022 us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
20000000 shares
CY2023Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
258000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
58086 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
53622 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23735000 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001678105
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23735000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60000000 shares
caro Foreign Currency Exchange Rate Translation Spot Gbp Usd Exchange Rate
ForeignCurrencyExchangeRateTranslationSpotGbpUsdExchangeRate
0 pure
caro Foreign Currency Exchange Rate Translation Average Gbp Usd Exchange Rate
ForeignCurrencyExchangeRateTranslationAverageGbpUsdExchangeRate
0 pure
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
258000 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-212268
dei Entity Registrant Name
EntityRegistrantName
CARO HOLDINGS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Address Address Line1
EntityAddressAddressLine1
7 Castle Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Sheffield
dei Entity Address Country
EntityAddressCountry
GB
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
S3 8LT
dei City Area Code
CityAreaCode
786
dei Local Phone Number
LocalPhoneNumber
755-3210
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23955000 shares
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12327 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2279 usd
CY2023Q3 us-gaap Other Receivables
OtherReceivables
203 usd
CY2023Q1 us-gaap Other Receivables
OtherReceivables
0 usd
CY2023Q3 us-gaap Notes Receivable Net
NotesReceivableNet
33305 usd
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
6000 usd
CY2023Q3 us-gaap Interest Receivable
InterestReceivable
531 usd
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
13 usd
CY2023Q3 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
12500 usd
CY2023Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
0 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
58866 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
8292 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
258000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
258000 usd
CY2023Q3 us-gaap Assets
Assets
316866 usd
CY2023Q1 us-gaap Assets
Assets
266292 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
61692 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
40476 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
18296 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
5290 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
58086 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
53622 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
28900 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
25000 usd
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
566665 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
266666 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
733639 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
391054 usd
CY2023Q3 us-gaap Liabilities
Liabilities
733639 usd
CY2023Q1 us-gaap Liabilities
Liabilities
391054 usd
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23735000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60000000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
237 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
600 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
473191 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
442828 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-891542 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-563910 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1341 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4280 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-416773 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-124762 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
316866 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
266292 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4885 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
0 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8227 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
0 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
11222 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
25875 usd
us-gaap Professional Fees
ProfessionalFees
48902 usd
us-gaap Professional Fees
ProfessionalFees
36447 usd
CY2023Q3 caro Management Consulting Fees Expense
ManagementConsultingFeesExpense
2488 usd
CY2022Q3 caro Management Consulting Fees Expense
ManagementConsultingFeesExpense
0 usd
caro Management Consulting Fees Expense
ManagementConsultingFeesExpense
9992 usd
caro Management Consulting Fees Expense
ManagementConsultingFeesExpense
0 usd
CY2023Q3 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
47207 usd
CY2022Q3 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
0 usd
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
110861 usd
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
0 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
65802 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
25875 usd
us-gaap Operating Expenses
OperatingExpenses
177982 usd
us-gaap Operating Expenses
OperatingExpenses
36447 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-65802 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-25875 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-177982 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-36447 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
106316 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
145005 usd
us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
338 usd
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
0 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
518 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
0 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9606 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5163 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-115584 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-149650 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-181386 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25875 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-327632 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36447 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-181386 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-25875 usd
us-gaap Net Income Loss
NetIncomeLoss
-327632 usd
us-gaap Net Income Loss
NetIncomeLoss
-36447 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10271 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5621 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-171115 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25875 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-322011 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36447 usd
CY2023Q3 caro Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.00
CY2022Q3 caro Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.00
caro Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.01
caro Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.00
CY2023Q3 caro Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
37163370 shares
CY2022Q3 caro Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
40000000 shares
caro Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
48581685 shares
caro Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
40000000 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-124762 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4650 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-146246 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-275658 usd
CY2023Q3 caro Cancellation Of Common Stock From Related Party Amount
CancellationOfCommonStockFromRelatedPartyAmount
0 usd
CY2023Q3 caro Issuance Of Common Stock For Conversion Of Debt Amount
IssuanceOfCommonStockForConversionOfDebtAmount
30000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10271 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-181386 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-416773 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-22003 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10572 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-32575 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-25875 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-58450 usd
us-gaap Net Income Loss
NetIncomeLoss
-327632 usd
us-gaap Net Income Loss
NetIncomeLoss
-36447 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
132000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-518 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
0 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-166 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-12500 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-7045 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
20803 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
43492 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
13006 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 usd
caro Increase Decrease Management Salary Payable
IncreaseDecreaseManagementSalaryPayable
5918 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-169089 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
27305 usd
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27305 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
3900 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
198000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
201900 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4542 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10048 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2279 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12327 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
caro Operating Expenses Paid By Related Parties
OperatingExpensesPaidByRelatedParties
0 usd
caro Operating Expenses Paid By Related Parties
OperatingExpensesPaidByRelatedParties
50345 usd
us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
369 shares
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
30000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-891542 usd
caro Foreign Currency Exchange Rate Translation Spot Gbp Usd Exchange Rate
ForeignCurrencyExchangeRateTranslationSpotGbpUsdExchangeRate
1.2210 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
600000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
566666 shares
CY2023Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
30000 usd
CY2023Q3 caro Common Stock Cancelled
CommonStockCancelled
36865000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60000000 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
20000000 shares
CY2022Q4 caro Unaffiliated Party Promissory Note Principal Amount
UnaffiliatedPartyPromissoryNotePrincipalAmount
25000 usd
CY2023Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
266666 usd

Files In Submission

Name View Source Status
0001640334-23-002222-index-headers.html Edgar Link pending
0001640334-23-002222-index.html Edgar Link pending
0001640334-23-002222.txt Edgar Link pending
0001640334-23-002222-xbrl.zip Edgar Link pending
caro-20230930.xsd Edgar Link pending
caro_10q.htm Edgar Link pending
caro_ex311.htm Edgar Link pending
caro_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
caro-20230930_cal.xml Edgar Link unprocessable
caro-20230930_def.xml Edgar Link unprocessable
caro-20230930_lab.xml Edgar Link unprocessable
caro-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
caro_10q_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending